Nouvelles

According to the WHO news announcement, the monkeypox epidemic has found about 26,000 confirmed cases of monkeypox in more than 88 countries and regions, constituting the highest level of alert of "public health event of international concern (PHEIC)"! This has raised concerns about the spread of the virus. According to the WHO, Europe is currently a high-risk area for monkeypox, and the rest of the world is at a medium-risk level.

En réponse à l'épidémie mondiale de monkeypox, Lepu Medical a développé un kit de test d'acide nucléique (PCR-Fluorescence Probe Method) pour le virus du monkeypox et a obtenu la certification CE de l'UE. Ce réactif fournit une solution pour aider les laboratoires de divers pays à effectuer efficacement des tests d'acide nucléique monkeypox et un diagnostic rapide.

Lepu Medical's monkeypox virus detection kit has the characteristics of high detection sensitivity, easy operability and strong stability. The kit can be quickly applied on multiple platforms such as Lepgen-96, Roche LightCycler 480 series, Bio-Rad CFX96, Shanghai Hongshi SLAN, and ABI 7500. At present, Lepu Medical has received orders and inquiries from many overseas countries and, at the same time, actively promotes the registration of this product in other overseas countries.